Clinical Application of SPECT-CT Imaging with 99mTc/PSMA T4 in patients with Recurrent Prostate Cancer

Conclusions: In conclusion SPECT-CT imaging with 99mTc-PSMA could be applied in patients with prostate cancer for the diagnosis of recurrent disease in order to determine personalized treatment for each individual patient. Specific uptake of this tracer, depicted by SPECT-CT images has clinical importance of identifying and assessment PSMA expression before consideration of Radio Ligand Therapy (RLT) with 177Lu-PSMA. SPECT-CT imaging with 99mTc-PSMA is promising and reliable nuclear medicine approach to monitor therapeutic effect after treatment - to detect progressive/active lesions or to report full/ partial response.
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Tags: PSMA and DCFPyL Source Type: research